Arthur Taveras

XFOR

Arthur Taveras serves as Chief Scientific Officer at X4 Pharmaceuticals, Inc. (XFOR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

6 trades

$121.0K

Net Position

Net Seller

$121.0K

Companies Traded

XFOR

Active Period

Feb 2023 – Oct 2024

6 total trades

Most Recent

Sell XFOR

Oct 8, 2024 · $43.3K

Arthur Taveras's Insider Trading at X4 Pharmaceuticals, Inc. (XFOR)

Buys

0 · $0.00

Sells

6 · $121.0K

Total Shares Bought

Total Shares Sold

177,371

XFOR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Oct 8, 2024	Sell	76,920	$0.56	$43.3K	388,026
Mar 11, 2024	Sell	14,235	$0.88	$12.6K	234,301
Feb 12, 2024	Sell	787	$1.01	$792.67	248,536
Nov 3, 2023	Sell	67,695	$0.73	$49.4K	249,323
Mar 13, 2023	Sell	16,806	$0.84	$14.1K	86,373
Feb 15, 2023	Sell	928	$0.93	$863.04	103,179

Related Insiders

Adam R Craig

Executive Chairman

XFORBuy · Oct 23, 2025

Mark Baldry

Chief Commercial Officer

XFORBuy · May 16, 2025

Explore More Insider Trading Data

XFOR Insider Trading Activity

View all insider trades at X4 Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity